{"References": [{"title": "SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis", "authors": "Brendon L Neuen, Tamara Young, Hiddo J L Heerspink, Bruce Neal, Vlado Perkovic, Laurent Billot, Meg J Jardine, Sophia Zoungas, Adeera Levin, Luxia Zhang, Richard Haynes, Martin J Landray, David C Wheeler, Hong Zhang, Kenneth W Mahaffey, David M Charytan, Clare Arnott, Severine Bompoint, Carinna Hockham, Meg Jardine", "journal": "The Lancet Diabetes & Endocrinology", "year": "2019", "volumes": "7", "first page": "845", "last page": "854", "DOI": "10.1016/S2213-8587(19)30256-6"}, {"title": "SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials", "authors": "Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, João Pedro Ferreira, Stuart J Pocock, Peter Carson, Inder Anand, Wolfram Doehner, Markus Haass, Michel Komajda, Aldo Pietro Maggioni, Faiez Zannad, Jyothis George, Martina Brueckmann, Waheed Jamal, Karen Coats, Cordula Zeller, John J V McMurray, Subodh Verma", "journal": "The Lancet", "year": "2020", "volumes": "396", "first page": "819", "last page": "829", "DOI": "10.1016/S0140-6736(20)31824-9"}, {"title": "Dapagliflozin in Patients with Chronic Kidney Disease", "authors": "David C Wheeler, Bergur V Stefánsson, Niels Jongs, Glenn M Chertow, Tom Greene, Hiddo J L Heerspink, John J V McMurray, Peter Rossing, Ricardo Correa-Rotter, Harpreet S Bajaj, Silvio E Inzucchi, Mikhail Kosiborod, Anna Maria Langkilde, Ofri Mosenzon, C David Sjöström, Robert D Toto, Anna Solini, Christoph Wanner", "journal": "New England Journal of Medicine", "year": "2021", "volumes": "385", "first page": "2295", "last page": "2307", "DOI": "10.1056/NEJMoa2025845"}, {"title": "Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes", "authors": "Christoph Wanner, Silvio E Inzucchi, John M Lachin, David Fitchett, Maximilian von Eynatten, Michaela Mattheus, Odd Erik Johansen, Hans J Woerle, Uli C Broedl, Bernard Zinman", "journal": "New England Journal of Medicine", "year": "2016", "volumes": "375", "first page": "323", "last page": "334", "DOI": "10.1056/NEJMoa1515920"}, {"title": "Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy", "authors": "Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull, Christopher P Cannon, George Capuano, Pei-Ling Chu, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol Pollock, David C Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Gary Meininger, Barry M Brenner, Kenneth W Mahaffey", "journal": "New England Journal of Medicine", "year": "2019", "volumes": "380", "first page": "2295", "last page": "2306", "DOI": "10.1056/NEJMoa1811744"}, {"title": "Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial", "authors": "John J V McMurray, David C Wheeler, Bergur V Stefánsson, Niels Jongs, Silvio E Inzucchi, Ricardo Correa-Rotter, Peter Rossing, C David Sjöström, Hiddo J L Heerspink, Glenn M Chertow, Tom Greene, Anna Maria Langkilde, Mikhail Kosiborod", "journal": "European Heart Journal", "year": "2021", "volumes": "42", "first page": "1216", "last page": "1227", "DOI": "10.1093/eurheartj/ehab094"}, {"title": "SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis", "authors": "Brendon L Neuen, Tamara Young, Hiddo J L Heerspink, Bruce Neal, Vlado Perkovic, Laurent Billot, Meg J Jardine, Sophia Zoungas, Adeera Levin, Luxia Zhang, Richard Haynes, Martin J Landray, David C Wheeler, Hong Zhang, Kenneth W Mahaffey, David M Charytan, Clare Arnott, Severine Bompoint, Carinna Hockham, Meg Jardine", "journal": "The Lancet Diabetes & Endocrinology", "year": "2019", "volumes": "7", "first page": "845", "last page": "854", "DOI": "10.1016/S2213-8587(19)30256-6"}, {"title": "SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials", "authors": "Thomas A Zelniker, Stephen D Wiviott, Itamar Raz, Kyungah Im, Erica L Goodrich, Sabina A Murphy, Ofri Mosenzon, Eri T Kato, Marc S Sabatine, Lawrence A Leiter, Darren K McGuire, John J V McMurray, Marc P Bonaca", "journal": "The Lancet", "year": "2019", "volumes": "393", "first page": "31", "last page": "39", "DOI": "10.1016/S0140-6736(18)32590-X"}, {"title": "Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure", "authors": "Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Sergio V Ferreira, Stuart J Pocock, Naveed Sattar, Jochen Brueckmann, Waheed Jamal, Karen Kimura, Janet Schnee, Cordula Zeller, Daniel Cotton, Edimar Bocchi, Michael Böhm, Dong-Ju Choi, Vijay Chopra, Eduardo Chuquiure, Nadia Giannetti, Stefan Janssens, Jian Zhang, Jose Ramon Gonzalez Juanatey, Sanjay Kaul, Hans-Peter Brunner-La Rocca, Bela Merkely, Stephen J Nicholls, Sergio Perrone, Ileana L Pina, Piotr Ponikowski, Naveed Sattar, Michele Senni, Marie-France Seronde, Jindrich Spinar, Iain Squire, Stefano Taddei, Christoph Wanner, Faiez Zannad", "journal": "New England Journal of Medicine", "year": "2020", "volumes": "383", "first page": "1413", "last page": "1424", "DOI": "10.1056/NEJMoa2022190"}, {"title": "Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes", "authors": "Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy, Deepak L Bhatt, Lawrence A Leiter, Darren K McGuire, John P H Wilding, Christian T Ruff, Ingrid A M Gause-Nilsson, Martin Fredriksson, Peter A Johansson, Anna-Maria Langkilde, Marc S Sabatine", "journal": "New England Journal of Medicine", "year": "2019", "volumes": "380", "first page": "347", "last page": "357", "DOI": "10.1056/NEJMoa1812389"}]}